EDSA
Edesa Biotech Inc
4.00$
-4.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.2% | 95.0% | 93.5% | 87.5% | 90.5% | 98.7% | 75.3% | 82.9% | 78.5% | 72.4% | 43.9% | 85.1% | |
| 92.8% | 38.1% | 57.3% | 59.2% | 35.9% | 88.0% | 67.0% | 53.8% | 61.3% | 60.3% | 27.2% | 79.8% | |
| 95.9% | 86.4% | 88.2% | 85.0% | 87.5% | 88.0% | 67.0% | 53.8% | 61.3% | 60.3% | 27.2% | 79.8% | |
| 0.4% | 1.5% | 0.7% | 0.0% | 0.4% | 3.8% | 0.8% | 22.6% | 10.8% | 7.0% | 7.1% | 4.8% | |
| – | 5.4% | 1.9% | 0.9% | 1.9% | -3.8% | -0.8% | – | -10.8% | – | – | – | |
| – | 4.8% | 5.8% | 0.0% | 0.1% | 1.3% | 1.6% | 0.8% | 0.3% | – | – | – | |
| – | – | – | – | – | – | 23.1% | 16.3% | 19.7% | 24.5% | 54.5% | 14.6% | |
| 46.8% | 22.9% | 4.8% | 4.2% | 4.2% | 8.1% | 15.4% | 10.5% | 18.9% | 20.7% | 48.1% | 8.0% | |
| 9.8% | 22.9% | 4.8% | 4.2% | 4.2% | 8.1% | 14.2% | 10.0% | 18.5% | 20.5% | 48.1% | 8.0% | |
| – | – | – | – | – | – | 0.6% | 0.5% | 0.2% | 0.8% | 0.5% | – | |
| 0.4% | 1.5% | 4.8% | 4.2% | 4.2% | 7.4% | 13.6% | 9.5% | 18.3% | 19.7% | 47.5% | 8.0% | |
| 53.2% | 77.1% | 95.2% | 95.8% | 95.8% | 91.9% | 84.6% | 89.5% | 81.1% | 79.3% | 51.9% | 92.0% | |
| -232.3% | -340.2% | -312.0% | -588.0% | -428.1% | -117.8% | -122.0% | -181.7% | -380.5% | -589.6% | -1,536.2% | -487.1% | |
| 1.2% | 1.8% | 1.6% | 0.3% | 3.9% | 11.5% | 11.4% | 11.8% | 18.1% | 32.2% | 83.8% | 42.0% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.